Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion description "[The purpose is to study the prognostic significance of tissue expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor (TATI) and serum concentration of trypsinogen-2, trypsin-2-API (complex of trypsin-2 with alpha-1-proteinase inhibitor), and TATI in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion evidence source_evidence_literature NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion SIO_000772 15269150 NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion wasDerivedFrom befree-20140225 NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_assertion wasGeneratedBy ECO_0000203 NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.
- befree-20140225 importedOn "2014-02-25" NP679661.RAImcb-py18QoigYYvBnpSjnxeeyPI9_UaU2e7LSCiG0M130_provenance.